The first dose of a two-dose COVID-19 vaccine regimen confers a robust immune response against the B117 and B1351 variants in people previously infected with the coronavirus—but not in those in those never infected, according to a new study led by researchers from Imperial College London, Queen Mary University of London, and University College London.
The Democratic Republic of the Congo (DRC) health ministry today declared the end of the country's 12th Ebola outbreak, given that 42 days have passed with no new cases since the last patient was released from treatment.
A bipartisan group of congressional representatives called on House appropriators last week to increase funding for the federal response to antimicrobial resistance (AMR).
To mark World Hand Hygiene Day, the World Health Organization (WHO) today called for countries to reduce inequalities in the availability of good hand hygiene and other infection prevention and control (IPC) measures.
Less than 0.1% of all COVID-positive patients in the Intermountain Healthcare system had probable or possible recurrence of SARS-CoV-2 infection, according to a PLOS One study yesterday.
The AstraZeneca-Oxford COVID-19 vaccine is associated with some increases in bleeding and clotting events, according to a BMJ study yesterday, but experts say the benefits outweigh the risks.
Saudi Arabia's Ministry of Health (MOH) today reported a new MERS-CoV case, which involves a 36-year-old man who died from his infection.
The man was from Hafr Al-Batin in the country's northeast. An investigation found that the man had been exposed to camels. He wasn't a healthcare worker and isn't thought to have contracted MERS-CoV (Middle East respiratory syndrome coronavirus) from another person.
Data from a cohort of US acute care hospitals (ACHs) reveal an association between total and broad-spectrum antibiotic use and hospital-onset Clostridioides difficile infection (HO-CDI) rates, researchers from the Centers for Disease Control and Prevention (CDC) reported today in Infection Control & Hospital Epidemiology.
Direct COVID-19 deaths may be more than double previous estimates, according to a report yesterday by the University of Washington's Institute for Health Metrics and Evaluation (IHME).
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Use of infectious diseases (ID) telemedicine for management of Staphylococcus aureus bacteremia (SAB) at 10 US hospitals resulted in similar outcomes compared with on-site consultation, researchers reported today in Open Forum Infectious Diseases.
Compared with non-pregnant women hospitalized with COVID-19, pregnant women with COVID-19 had lower in-hospital death rates, according to a research letter in the Annals of Internal Medicine today.
CARB-X announced today that it is awarding Australian diagnostics company SpeeDx up to $1.8 million to develop a rapid molecular diagnostic test for chlamydia and gonorrhea infections.
Twice as many mothers with babies 6 months or younger reported postpartum depression during the first UK COVID-19–related lockdown, according to a Frontiers in Psychology study yesterday.
Watching a brief video about antibiotic treatment prior to a family practitioner visit reduced patients' expectations about receiving antibiotics for upper respiratory tract infections (URTIs) but had no influence on physician prescribing, according to a randomized controlled trial published this week in the Annals of Family Medicine.
An analysis of administrative claims data in Japan found that newer, third-generation fluoroquinolones were not associated with an increased risk of Achilles tendon rupture, Japanese researchers reported this week in the Annals of Family Medicine.
A rapid, cartridge-based polymerase chain reaction (PCR) platform developed by scientists at Johns Hopkins University for detecting gonorrhea infections and providing antibiotic susceptibility results showed promising results in a study published this week in Science Translational Medicine.
A crowdsourcing appeal for creative solutions for safely reopening the University of North Carolina at Chapel Hill amid the COVID-19 pandemic in fall 2020 netted 82 submissions from 110 students, faculty, and staff, according to a qualitative study today in JAMA Network Open.
Almost two thirds of homeless patients hospitalized for COVID-19 were of non-White descent and more than 80% had at least one comorbidity, according to a descriptive study in The Journal of Infectious Diseases yesterday.
An investigation into a Listeria moncytogenes outbreak linked to a New Jersey company's queso fresco cheese has ended, with 14 cases reported in four states, the US Centers for Disease Control and Prevention (CDC) said May 14 in a final update.
Fewer high-risk outpatients with mild or moderate COVID-19 needed hospitalization or died within 28 days when given bamlanivimab soon after infection compared with their matched peers, finds an observational study yesterday in Open Forum Infectious Diseases.
CARB-X announced today that it is awarding up to $4.1 million to Summit Therapeutics of Cambridge, Massachusetts, to develop a first-in-class antibiotic to treat multidrug-resistant bacterial infections.
CARB-X announced today that it is awarding Swiss drug maker Basilea Pharmaceutica International up to $2.7 million to develop a novel class of antibiotics to treat gram-negative bacterial infections.
One in seven US adult COVID-19 patients developed at least one new illness requiring medical care after recovery from their infection in 2020, finds an observational study yesterday in BMJ.
